s6y

Aptevo Therapeutics Inc.

Ticker
APVO
CIK
1671584
Industry
Pharmaceutical Preparations

Financials 45

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 45 financials filings

News 172

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 172 news filings

Ownership 305

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 305 ownership filings

Prospectus 67

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  7. S-1 General form of registration statement for all companies including face-amount certificate companies
  8. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 424B4 Prospectus filed pursuant to Rule 424(b)(4)

All 67 prospectus filings

Proxies 41

  1. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

All 41 proxies filings

Other 117

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G/A
  3. EFFECT Notice of Effectiveness
  4. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  5. UPLOAD Letter (PDF)
  6. D Exempt (Private) Offering
  7. SCHEDULE 13G/A
  8. ARS Annual report to security holders
  9. SCHEDULE 13G
  10. SCHEDULE 13G/A

All 117 other filings